E-cigarettes may not significantly cut heart disease risk

E-cigarettes may not significantly reduce smokers' risk for heart disease, a new study has found.
Nicotine, the major addictive substance in cigarette smoke, contributes to smokers' higher risk of developing atherosclerosis, the primary cause of heart attacks, according to the research.
These findings suggest that e-cigarettes, the battery-powered devices that deliver nicotine in steam without the carcinogenic agents of tobacco smoke, may not significantly reduce smokers' risk for heart disease, said Chi-Ming Hai, from Brown University.
Although e-cigarettes are being promoted as "safe" nicotine delivery systems, the safety of nicotine has been disputed, partly because the mechanism by which it acts on the circulatory system has not been well understood.

Hai's research on human and rat vascular smooth muscle cells provides evidence of a link between nicotine and atherosclerosis.
In experiments, nicotine appeared to drive the formation of a kind of cellular drill called podosome rosettes, which are members of the invadosome family, consisting of invadopodia, podosomes and podosome rosettes.

These specialised cell surface assemblies degrade and penetrate the tissue during cell invasion.
Invasion of vascular smooth muscle cells from the middle layer of the arterial wall (media) to the inner layer of the arterial wall (intima) contributes substantially to plaque formation in atherosclerosis.
According to Hai, a potential clinical implication of these findings is that replacing cigarette smoking by nicotine administration may not bring much benefit to lowering the risk of developing atherosclerosis.

The study was presented at the American Society for Cell Biology Annual Meeting in New Orleans.